Blog

Sipuleucel-T (Provenge) has been authorised since September 2014 for use by men with metastatic prostate cancer who have little or no ...

[:content [\1 \4 \space \D \e \c \e \m \b \e \r \space \2 \0 \1 \3 \space \- \space \B \M \S \space \& \space \A \s \t \r \a \Z \e \n \e \c \a \space \h \a \v \e \  \p \u \l \l \e \d \space \t \h \e \i \r \space \d \i \a \b \e \t \e \s \space \t \r \e \a \t \m \e \n \t \space \F \o \r \x \i \g \a \space \( \d \a \p \a \g \l \i \f \l \o \z \i \n \) \space \f \r \o \m \space \t \h \e \space \G \e \r \m \a \n \space \m \a \r \k \e \t \space \a \f \t \e \r \space \t \h \e \space \c \o \m \p \a \n \i \e \s " ..."]]

[:content [\3 \1 \space \M \a \r \c \h \space \2 \0 \1 \4 \space \- \  " ..."]]

Ruxolitinib (trade name: Jakavi) has been approved since August 2012 for the treatment of adults with myelofibrosis. In an early ...

U.S. biotechnology company Gilead has conceded its first discounts in Germany on its key hepatitis C drugs Sovaldi and Harvoni, German business weekly WirtschaftsWoche ...

Enzalutamide (trade name: Xtandi) has been approved since December 2014 for men who have metastatic prostate cancer that is not ...

[:content [\D \a \b \r \a \f \e \n \i \b \space \m \e \s \y \l \a \t \e \space \( \T \a \f \i \n \l \a \r \) \space \h \a \s \space \b \e \e \n \space \a \p \p \r \o \v \e \d \space \i \n \space \G \e \r \m \a \n \y \space \s \i \n \c \e \space \A \u \g \u \s \t \space \2 \0 \1 \3 \space \f \o \r \space \t \h \e \space \t \r \e \a \t \m \e \n \t \space \o \f \space \p \a \t \i \e \n \t \s \space \w \i \t \h \  \a \d \v \a \n \c \e \d \space \m \e \l \a \n \o \m \a \. \space \I \n \space \a \n " ..."]]

[:content [\1 \space \A \p \r \i \l \space \2 \0 \1 \4 \space \- \  \R \a \d \i \u \m \space \R \a \2 \2 \3 \space \d \i \c \h \l \o \r \i \d \e \space \( \X \o \f \i \g \o \) \space \h \a \s \space \b \e \e \n \space \a \p \p \r \o \v \e \d \space \s \i \n \c \e \space \N \o \v \e \m \b \e \r \space \2 \0 \1 \3 \space \f \o \r \space \m \e \n \space \w \i \t \h \space \a \d \v \a \n \c \e \d \space \p \r \o \s \t \a \t \e \space \c \a \n \c \e \r \, \space \i \n " ..."]]

In April 2014 the EU Parliament and Council commissioned the European Medicines Agency (EMA) to establish a publicly accessible database ...

Eisai announced today that its German sales company Eisai GmbH has resubmitted its first-in-class anti-epilepsy drug Fycompa (perampanel) to the German Federal ...

[:content [\2 \space \D \e \c \e \m \b \e \r \space \2 \0 \1 \3 \space \- \space \S \a \x \a \g \l \i \p \t \i \n \space \h \y \d \r \o \c \h \l \o \r \i \d \e \space \( \O \n \g \l \y \z \a \) \space \h \a \s \space \b \e \e \n \space \a \p \p \r \o \v \e \d \space \a \l \s \o \space \a \s \space \m \o \n \o \t \h \e \r \a \p \y \space \i \n \space \G \e \r \m \a \n \y \space \s \i \n \c \e \space \J \u \l \y \space \2 \0 \1 \3 \space \f \o \r \space \c \e \r \t \a \i \n " ..."]]

Internationally health economic evaluations (HEEs) form a legally regulated fixed component in health-care decisions. This applies particularly to the drug ...

1 July 2015 - Novo Nordisk today announced that the company has decided to cease distribution of its once-daily basal insulin ...

Eisai Co., Ltd.  announced today that the German Federal Joint Committee (G-BA) has determined no additional benefit for its in-house ...